Analystreport

Orchard Therapeutics PLC - (NASDAQ: ORTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $17.00 price target on the stock, down previously from $25.00.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report